70% of study participants said they would like to use longer-acting regimens instead of daily pills.
POZ news story
More than two thirds people currently taking daily pills for HIV treatment would be willing to switch to a long-acting regimen, according to a systematic review and meta-analysis published in the journal AIDS. Willingness varied across studies, however, and most were conducted in high-income countries.
“Given that long-acting regimen preferences are highly individualized and difficult to predict, eligible individuals should be informed about this option where the clinical and contextual situation allows,” the review authors wrote.
Read the full news story here.
Source : POZ
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.